Brokerages Set Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) PT at $34.42
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven analysts that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average […]
More Stories
Cassady Schiller Wealth Management LLC Acquires 1,337 Shares of Exxon Mobil Co. (NYSE:XOM)
Cassady Schiller Wealth Management LLC raised its holdings in Exxon Mobil Co. (NYSE:XOM – Free Report) by 14.9% during the...
S&CO Inc. Has $4.06 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)
S&CO Inc. lifted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 24.5% during the 3rd...
S&CO Inc. Decreases Holdings in AT&T Inc. (NYSE:T)
S&CO Inc. lowered its position in AT&T Inc. (NYSE:T – Free Report) by 24.0% during the third quarter, HoldingsChannel.com reports....
Lucid Diagnostics Announces Redemption of Senior Convertible Note and Issuance of 2024 Convertible Notes
Lucid Diagnostics Inc. (NASDAQ: LUCD) recently disclosed in an 8-K SEC filing dated November 8, 2024, that the company has...
Atlanta Consulting Group Advisors LLC Raises Stock Position in Marathon Petroleum Co. (NYSE:MPC)
Atlanta Consulting Group Advisors LLC boosted its position in Marathon Petroleum Co. (NYSE:MPC – Free Report) by 2.5% during the...
Shore Bancshares, Inc. (NASDAQ:SHBI) Short Interest Down 18.0% in October
Shore Bancshares, Inc. (NASDAQ:SHBI – Get Free Report) was the recipient of a significant drop in short interest in the...